Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - PRA Health Sciences, Inc. | q42019ex322.htm |
| EX-32.1 - EXHIBIT 32.1 - PRA Health Sciences, Inc. | q42019ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - PRA Health Sciences, Inc. | q42019ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - PRA Health Sciences, Inc. | q42019ex311.htm |
| EX-21.1 - EXHIBIT 21.1 - PRA Health Sciences, Inc. | q42019sublistex211.htm |
| EX-10.22 - EXHIBIT 10.22 - PRA Health Sciences, Inc. | q42019rsagrant.htm |
| EX-10.21 - EXHIBIT 10.21 - PRA Health Sciences, Inc. | q42019nqsogrant.htm |
| EX-4.1 - EXHIBIT 4.1 - PRA Health Sciences, Inc. | q42019ex41.htm |
| 10-K - 10-K - PRA Health Sciences, Inc. | q4201910kdocument.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-225313, 333-200160, and 333-221259 on Form S-8 and Registration Statement No. 333-230102 on Form S-3 of our reports dated February 21, 2020, relating to the consolidated financial statements of PRA Health Sciences, Inc. and subsidiaries (which report expressed an unqualified opinion and includes an explanatory paragraph relating to the adoption of new accounting standards), and the effectiveness of PRA Health Sciences, Inc.'s internal control over financial reporting, appearing in this Annual Report on Form 10-K of PRA Health Sciences, Inc. for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP
Raleigh, North Carolina
February 21, 2020